Tackling Racial Disparities in Breast Cancer Risk Assessment - ET05

Saturday, May 18, 2024

2:45 PM - 3:45 PM PDT

Location: 3

CME Credits 1

Sub Topic: Preventive care

Myrlene Jeudy, MD, FACOG

Assistant Professor of Obstetrics and Gynecology
Virgina Commonwealth Univesity
Virginia Commonwealth University
Richmond, VA, United States
Monique Swain, MD (she/her/hers)

Residency Program Director and Clinical Associate Professor
Henry Ford Health/Michigan State University College of Human Medicine
Michigan State University College of Human Medicine
Canton, MI, United States
Ashley Dedmon (she/her/hers)

Lived Experience Expert/BRCA2+
Volunteer: Black & BRCA Initiative at Penn Medicine’s Basser Center for BRCA
Houston, TX, United States

Session Description
Black women have a breast cancer mortality that is higher than other racial/ethnic groups in the US. Compared to non-Hispanic White women, Black women are diagnosed with breast cancer at younger ages and disproportionally diagnosed triple negative breast cancer (TNBC). Both early age of onset and higher frequency of TNBC are associated with higher risk for Hereditary Breast Cancer. Breast cancer risk assessment and genetic evaluation/testing provide women with information needed to make informed decisions to reduce their cancer risk. This session will enhance awareness of these inequities and assist providers in identifying/educating patients at increased risk of breast cancer.

Disclosure(s):

Myrlene Jeudy, MD: No financial relationships to disclose

Monique Swain, MD: No financial relationships to disclose

Ashley Dedmon, MPH: No financial relationships to disclose